TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro
In: BMC Medicine, Jg. 22 (2024-12-01), Heft 1
Online
academicJournal
Zugriff:
Titel: |
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro
|
---|---|
Autor/in / Beteiligte Person: | Duan, Qing-Qing ; Wang, Han ; Su, Wei-Ming ; Gu, Xiao-Jing ; Shen, Xiao-Fei ; Jiang, Zheng ; Ren, Yan-Ling ; Cao, Bei ; Li, Guo-Bo ; Wang, Yi ; Chen, Yong-Ping |
Link: | |
Zeitschrift: | BMC Medicine, Jg. 22 (2024-12-01), Heft 1 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 1741-7015 (print) |
DOI: | 10.1186/s12916-024-03314-1 |
Sonstiges: |
|